S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 94 900 KRW 0.74% Market Closed
Market Cap: 1.9T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note

ST Pharm Co Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ST Pharm Co Ltd
Additional Paid In Capital Peer Comparison

Comparables:
207940
F
220100
L
141080
C
268600
E
456070

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
S
ST Pharm Co Ltd
KOSDAQ:237690
Additional Paid In Capital
â‚©225.9B
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Additional Paid In Capital
â‚©6.5T
CAGR 3-Years
38%
CAGR 5-Years
21%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Additional Paid In Capital
â‚©120.7B
CAGR 3-Years
9%
CAGR 5-Years
32%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Additional Paid In Capital
â‚©97.5B
CAGR 3-Years
-19%
CAGR 5-Years
-12%
CAGR 10-Years
11%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Additional Paid In Capital
â‚©170B
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
N/A
E
ENCell Co Ltd
KOSDAQ:456070
Additional Paid In Capital
â‚©96.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ST Pharm Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
225.9B KRW

Based on the financial report for Jun 30, 2024, ST Pharm Co Ltd's Additional Paid In Capital amounts to 225.9B KRW.

What is ST Pharm Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
6%

Over the last year, the Additional Paid In Capital growth was 21%. The average annual Additional Paid In Capital growth rates for ST Pharm Co Ltd have been 10% over the past three years , 6% over the past five years .

Back to Top